APA (7th ed.) Citation

JW, F., AK, P., S, P., M, D., DA, J., S, B., . . . J, B. (2006). Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells. Cancer immunology, immunotherapy : CII, 55(10), 1209. https://doi.org/10.1007/s00262-005-0106-6

Chicago Style (17th ed.) Citation

JW, Fay, Palucka AK, Paczesny S, Dhodapkar M, Johnston DA, Burkeholder S, Ueno H, and Banchereau J. "Long-term Outcomes in Patients with Metastatic Melanoma Vaccinated with Melanoma Peptide-pulsed CD34(+) Progenitor-derived Dendritic Cells." Cancer Immunology, Immunotherapy : CII 55, no. 10 (2006): 1209. https://doi.org/10.1007/s00262-005-0106-6.

MLA (9th ed.) Citation

JW, Fay, et al. "Long-term Outcomes in Patients with Metastatic Melanoma Vaccinated with Melanoma Peptide-pulsed CD34(+) Progenitor-derived Dendritic Cells." Cancer Immunology, Immunotherapy : CII, vol. 55, no. 10, 2006, p. 1209, https://doi.org/10.1007/s00262-005-0106-6.